1.
Am J Trop Med Hyg
; 107(4): 785-788, 2022 10 12.
Article
in English
| MEDLINE
| ID: mdl-36067991
ABSTRACT
The immunosuppressive effect of methotrexate has rarely been associated with reactivation of cutaneous leishmaniasis. Here we present a case of a cutaneous leishmaniasis patient with atypical clinical symptoms without splenomegaly but with cutaneous manifestations after treatment of rheumatoid arthritis with methotrexate and blood recovery of the parasite. Next-generation sequencing was used to identify Leishmania infantum chagasi in the patient's blood sample.